Back to results
US 2012/0252730 A1Published application
Platelet aggregation inhibitors
AssigneeThe University of Chicago
InventorsMilan Mrksich, Juan Sanchez-Cortes
Life of this patent
Estimating the term…
Abstract
Peptides and cyclized analogs thereof that are useful as platelet aggregation inhibitors in the treatment of cardiac disease, including acute coronary syndrome are disclosed.
Claims25
A compound of formula I, II, III, IV, or V:
- wherein
- represents a bond;
- X1 and X5 are independently selected residues capable of forming a bond between X1 and X5 to obtain a cyclic compound;
- X2 is absent or is a sequence of independently selected amino acids that is from one to six amino acids in length;
- X4 is absent or is a sequence of independently selected amino acids that is from one to six amino acids in length;
- wherein the sum of the length of amino acids in X2 plus X4 is from zero to 6 amino acids;
- X3 is a hydrophobic amino acid residue;
- and
- G* is glycyl or sarcosyl;
- Y1 is absent, H, acetyl, or an amino protecting group;
- Y2 is —OH, NH2, or a carboxyl protecting group;
- wherein one or more peptide linkages of Formulas I-V may optionally be replaced by a linkage selected from the group consisting of —CH2NH—, —CH2S—, CH2CH2—, —CH═CH— (cis and trans), —COCH2—, —CH(OH)CH2— and —CH2SO—;
- or a pharmaceutically acceptable salt thereof;
- with the proviso that the following peptides are excluded from the scope of formula (I):
- (SEQ ID NO:
- 1)
- HHLGGAKQAGDV,
- (SEQ ID NO:
- 3)
- LGGAKQAGDV,
- and
- (SEQ ID NO:
- 10)
- LQAGDV.
21 more elements
Dependencies are inferred from the claim text.